The relevant clinical information in the datasets is not complete, such as missing disease duration, treatment history and skin lesion sites, etc. Thirdly, the function of the key gene CCR5 and its upstream/downstream pathways in keloid and AD need to be further verified, which will be the focus of our future work. This evidence concerns the gene CCR5 and Alzheimer disease.